"Typically you'll see that
in the smaller PBMs, where they leverage rebate aggregation from a larger
PBM…they kind of pick their suite. And that's where it seems Express Scripts is
headed, selling a suite of services to PBMs to leverage if they want."
— Brian Anderson, a principal at Milliman Inc., spoke with AIS's
RADAR on Drug Benefits
about Prime Therapeutics' recent partnership with Cigna's Express Scripts, and
what it means for the future of the PBM industry.
Subscribers may read the RADAR on Drug Benefits article in which this quote appeared online. Learn more about subscribing to AIS Health's publications
No comments:
Post a Comment